Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis

被引：0
|
作者：
María Rosario Blasco
Antonio Ramos
Celia García Malo
Antonio García-Merino
机构：
[1] Hospital Universitario Puerta de Hierro-Majadahonda,
来源：
Journal of Neurology | 2017年 / 264卷
关键词：
Multiple Sclerosis; Ganciclovir; Pericardial Effusion; Pericarditis; Alemtuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：168 / 169
页数：1
相关论文
共 50 条
  • [1] Acute pneumonitis and pericarditis related to alemtuzumab therapy in relapsing-remitting multiple sclerosis
    Rosario Blasco, Maria
    Ramos, Antonio
    Garcia Malo, Celia
    Garcia-Merino, Antonio
    [J]. JOURNAL OF NEUROLOGY, 2017, 264 (01) : 168 - 169
  • [2] Alemtuzumab: A new therapy for active relapsing-remitting multiple sclerosis
    Hartung, Hans-Peter
    Aktas, Orhan
    Boyko, Alexey N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 22 - 34
  • [3] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [4] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    [J]. IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [5] Alemtuzumab-Related thyroid dysfunction in patients with relapsing-remitting Multiple Sclerosis
    Shaamile, F.
    O'Connor, A.
    McQuaid, S. E.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S248 - S248
  • [6] Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis
    Brown, J. William L.
    Coles, Alasdair J.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 131 - 138
  • [7] Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis
    Gomez, Pablo Rodriguez de Vera
    Muros, Mariola Mendez
    Cuadro, Alberto Torres
    de Miera, Francisco Javier Toyos Saenz
    Ruiz, Rocio Lopez
    Vazquez, Raquel Guerrero
    Gonzalez, Juan Jesus Garcia
    Hermosilla, Antonio Manuel Garrido
    Hernandez, Tomas Martin
    [J]. JOURNAL OF NEUROLOGY, 2024, 271 (01) : 486 - 496
  • [8] COST-EFFECTIVENESS OF ALEMTUZUMAB FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Kohn, Christine G.
    Costales, Victoria
    Coleman, Craig I.
    Young, Dan
    Limone, Brendan L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1413 - 1414
  • [9] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [10] Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis
    Ranganathan, Usha
    Kaunzner, Ulrike
    Foster, Stacyann
    Vartanian, Timothy
    Perumal, Jai S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (04) : 553 - 554
12345